Topotecan Hydrochloride Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-762

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topotecan Hydrochloride (NDC 63323-762). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Top0e 0003 01

FDA Label Image

Top0e 0003 02

FDA Label Image

Top0e 0003 03

FDA Label Image

Top0e 0003 04

FDA Label Image

Top0e 0003 05

Top0e 0003 05
Topotecan Hydrochloride for injection is a cytotoxic agent used for intravenous administration after dilution. Each vial contains 4 mg of base. It is available only on prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.